US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist
  • 2.260
  • +0.040+1.80%
Close Nov 27 16:00 ET
  • 2.260
  • 0.0000.00%
Post 18:40 ET
218.52MMarket Cap-945P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADC Therapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
18.50M
18.46M
-31.00K
Miss Est.
+27.61%
+27.40%
-0.17%
EPS
-0.39
-0.42
-0.03
Miss Est.
+31.99%
+26.32%
-6.49%
Analyst Rating
Strong Buy

Nov 12, 2024

ADC Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 20.271M--
--2024/Q4-- / 18.850M--
Nov 7, 20242024/Q318.464M / 18.495M--
Aug 6, 20242024/Q217.410M / 18.798M--
May 6, 20242024/Q118.053M / 18.102M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 20.271M--
--2024/Q4-- / 18.850M--
Nov 7, 20242024/Q318.464M / 18.495M--
Aug 6, 20242024/Q217.410M / 18.798M--
May 6, 20242024/Q118.053M / 18.102M--

Unlock Free Earnings Estimates

ADC Therapeutics Earnings Reports

  • ADC Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 10:48 ET

  • ADC Therapeutics | 8-K: ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update

    Nov 7 07:58 ET

  • ADC Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 10:08 ET

  • ADC Therapeutics | 8-K: ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

    Aug 6 07:38 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data